 News
|
| June 2008 |
| Dr. Baeck joins Aqueous |
Aqueous Biomedical hires Dr. Johan Baeck as new CEO. Dr Baeck brings over 20 years of life science industry experience to the team, including extensive experience managing human trials.
|
| September 2007 |
| Japan Awards Patent |
Japan issues patent for ABI's Oculieve glaucoma drainage device.
|
| June 2007 |
| ABI Article Published |
ABI research related to soft tissue reaction to glaucoma implants published in Ophthalmologica, Europe's leading ophthalmic journal. Click here for article.
|
| |
Contact
|
Phone:
719.459.2072
email:
|
|
|
| Aqueous Biomedical Inc. (ABI), is a privately held biomedical device company located in Colorado Springs, Colorado. |
 Aqueous Biomedical has made new discoveries about how cells respond to chemical interactions and physical forces caused by biomedical implants. Using this knowledge, we are developing unique biocompatible materials and geometric designs that work with the body. This revolutionary approach can be applied across a wide range of technologies, including stents, shunts, artificial organs, and drug delivery devices, to make these implants more effective and longer lasting. |
|
|
|
Our first product is the Oculieve™ shunt, uniquely designed to control over-pressurization inside the eye caused by glaucoma and prevent the onset of blindness. We are also currently developing bio-friendly coating materials for cardiovascular stents that prevent restenosis, and modifications for implanted drug delivery devices to prevent scarring and clogging. |
 |
|
|
|
|
|
